Recently, some studies reported that several orphan G protein-coupled receptors (GPCRs), GPR41, GPR43, and GPR120, possess potential as fresh drug targets for disorders of metabolism, including T2D and obesity (70). Here, FFAR4 is linked to obesity due to melanocortin 4 receptor deficiency.